BIM
UTHR icon

BlackRock Investment Management’s United Therapeutics UTHR Stock Holding History

BlackRock Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$26M Buy
180,979
+20,470
+13% +$2.61M 0.03% 514
2016
Q3 		$19M Buy
160,509
+7,363
+5% +$885K 0.02% 624
2016
Q2 		$16.2M Sell
153,146
-245,494
-62% -$27.4M 0.02% 663
2016
Q1 		$44.4M Sell
398,640
-821,356
-67% -$104M 0.06% 313
2015
Q4 		$191M Buy
1,219,996
+16,161
+1% +$2.35M 0.24% 94
2015
Q3 		$158M Buy
1,203,835
+37,915
+3% +$6.08M 0.21% 100
2015
Q2 		$203M Sell
1,165,920
-112,978
-9% -$20.3M 0.25% 91
2015
Q1 		$221M Sell
1,278,898
-24,263
-2% -$3.7M 0.29% 79
2014
Q4 		$169M Sell
1,303,161
-23,894
-2% -$3.08M 0.22% 104
2014
Q3 		$171M Buy
1,327,055
+387,593
+41% +$40M 0.24% 90
2014
Q2 		$83.1M Sell
939,462
-232,262
-20% -$22.3M 0.11% 183
2014
Q1 		$110M Buy
1,171,724
+97,689
+9% +$9.99M 0.16% 134
2013
Q4 		$121M Buy
1,074,035
+380,675
+55% +$34.3M 0.18% 116
2013
Q3 		$54.7M Buy
693,360
+205,690
+42% +$15M 0.09% 207
2013
Q2 		$32.1M Buy
+487,670
New +$31.4M 0.06% 300

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BlackRock Investment Management's UTHR Position: Q4 2016 in Review

BlackRock Investment Management increased its United Therapeutics (UTHR) stake by 13% in Q4 2016, buying an estimated $2.61M and bringing the position to 180,979 shares worth $26M. The position accounts for 0.03% of the portfolio, ranked #514.

BlackRock Investment Management first reported a position in UTHR in Q2 2013 and has held it in 15 quarters since. The position peaked at $221M in Q1 2015. 406 funds tracked by Wall St. Rank hold UTHR as of Q4 2016.

  • BlackRock Investment Management held 180,979 shares of United Therapeutics worth $26M as of Q4 2016.
  • BlackRock Investment Management bought 20,470 United Therapeutics shares in Q4 2016, an estimated $2.61M.
  • United Therapeutics made up 0.03% of BlackRock Investment Management's portfolio in Q4 2016, its #514 holding.
  • BlackRock Investment Management first reported a position in United Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's United Therapeutics position peaked at $221M in Q1 2015.
  • 406 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.